Literature DB >> 15196700

Activin isoforms signal through type I receptor serine/threonine kinase ALK7.

Kunihiro Tsuchida1, Masashi Nakatani, Norio Yamakawa, Osamu Hashimoto, Yoshihisa Hasegawa, Hiromu Sugino.   

Abstract

Activins play a fundamental role in cell differentiation and development. Activin A signaling is mediated through a combination of activin type II receptors (ActRIIs) and the activin type IB receptor, ALK4. Signaling receptors of other activin isoforms remain to be elucidated. Here, we found that activin AB and activin B are ligands for ALK7. ALK7 is an orphan receptor serine/threonine kinase expressed in neuroendocrine tissues including pancreatic islets. The combination of ActRIIA and ALK7, preferred by activin AB and activin B but not by activin A, is responsible for activin-mediated secretion of insulin from pancreatic beta cell line, MIN6. In contrast, all activins activate a combination of ActRIIA and ALK4 with various levels of potency. Thus, variation in activin signaling through type I receptors is dependent upon homo- and heterodimeric assembly of activin isoforms. Thus, the differential combination of receptor heterodimers mediates variation in activin isoform signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196700     DOI: 10.1016/j.mce.2004.03.009

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  47 in total

Review 1.  CNS repair and axon regeneration: Using genetic variation to determine mechanisms.

Authors:  Andrea Tedeschi; Takao Omura; Michael Costigan
Journal:  Exp Neurol       Date:  2016-05-06       Impact factor: 5.330

2.  Dicer deficiency reveals microRNAs predicted to control gene expression in the developing adrenal cortex.

Authors:  Kenneth T Krill; Katherine Gurdziel; Joanne H Heaton; Derek P Simon; Gary D Hammer
Journal:  Mol Endocrinol       Date:  2013-03-21

Review 3.  TGF-β Superfamily Regulation of Follicle-Stimulating Hormone Synthesis by Gonadotrope Cells: Is There a Role for Bone Morphogenetic Proteins?

Authors:  Luisina Ongaro; Gauthier Schang; Catherine C Ho; Xiang Zhou; Daniel J Bernard
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

4.  Reciprocal modulation of adult beta cell maturity by activin A and follistatin.

Authors:  M Szabat; J D Johnson; J M Piret
Journal:  Diabetologia       Date:  2010-05-04       Impact factor: 10.122

5.  Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity.

Authors:  Lara Bonomi; Melissa Brown; Nathan Ungerleider; Meghan Muse; Martin M Matzuk; Alan Schneyer
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-26       Impact factor: 4.310

6.  Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.

Authors:  Marcin Chrusciel; Susanna Vuorenoja; Bidut Mohanty; Adolfo Rivero-Müller; Xiangdong Li; Jorma Toppari; Ilpo Huhtaniemi; Nafis A Rahman
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

Review 7.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 8.  The biology of activin: recent advances in structure, regulation and function.

Authors:  Yin Xia; Alan L Schneyer
Journal:  J Endocrinol       Date:  2009-03-09       Impact factor: 4.286

9.  Activin signaling as an emerging target for therapeutic interventions.

Authors:  Kunihiro Tsuchida; Masashi Nakatani; Keisuke Hitachi; Akiyoshi Uezumi; Yoshihide Sunada; Hiroshi Ageta; Kaoru Inokuchi
Journal:  Cell Commun Signal       Date:  2009-06-18       Impact factor: 5.712

10.  ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease.

Authors:  Lena M S Carlsson; Peter Jacobson; Andrew Walley; Philippe Froguel; Lars Sjöström; Per-Arne Svensson; Kajsa Sjöholm
Journal:  Biochem Biophys Res Commun       Date:  2009-03-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.